Results 261 to 270 of about 625,035 (300)

Fulminant type 1 diabetes with high‐titer anti‐glutamic acid decarboxylase antibodies: Likely rapid progression from stage 2 to 3

Journal of Diabetes Investigation, EarlyView.
Abstract A 61‐year‐old man visited our hospital with a sudden onset of polydipsia and polyuria occurring 5 days prior, accompanied by a 5‐kg weight loss. A month prior, his glycated hemoglobin level was 6.2%. Precisely 8 days before the first visit, he had a fever, and hyperglycemic symptoms began shortly thereafter.
Megumi Sato, Junnosuke Miura, Hikaru Oyatsu, Yuka Yoshida, Shota Mochizuki, Michio Otsuki, Tomoko Nakagami   +6 more
wiley   +1 more source

A mucus layer derived from porcine intestinal organoid air-liquid interface monolayer attenuates swine enteric coronavirus infection by antiviral activity of Muc2. [PDF]

BMC Biol
Yang N, Li Y, Cai Y, Liu Y, Zhang Y, Fu Y, Tan C, Willems L, Liu G.   +8 more
europepmc   +1 more source

A selective C5a-derived peptidomimetic enhances IgG response following inactivated SARS-CoV-2 immunization and confers rapid disease resolution following murine coronavirus infection. [PDF]

Front Immunol
Neville AJ, Conrin ME, Schulze TT, Davis PH.   +3 more
europepmc   +1 more source

Antiviral Effect of Antimicrobial Peptoid TM9 and Murine Model of Respiratory Coronavirus Infection. [PDF]

Pharmaceutics
Lebedev M, Benjamin AB, Kumar S, Molchanova N, Lin JS, Koster KJ, Leibowitz JL, Barron AE, Cirillo JD.   +8 more
europepmc   +1 more source

Neurotropic Murine β-Coronavirus Infection Causes Differential Expression of Connexin 47 in Oligodendrocyte Subpopulations Associated with Demyelination. [PDF]

Mol Neurobiol
Das S, Shaw AK, Das Sarma S, Koval M, Das Sarma J, Maulik M.   +5 more
europepmc   +1 more source

Evolution of Nursing Education, Research and Practice: Insights to Foster Nurse Solidarity and Address Future Challenges

Journal of Advanced Nursing, EarlyView.
William H. C. Li
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

SARS Coronavirus Anti-Infectives

Recent Patents on Anti-Infective Drug Discovery, 2006
Severe acute respiratory syndrome (SARS) emerged in late 2002 and was controlled in July 2003 by public health measures. Its causative agent, SARS coronavirus (SARS-CoV) jumped from an animal reservoir to humans and has the potential to re-emerge. Following the sequencing of the genetic code and the deciphering of some of the functions of its proteins,
openaire   +2 more sources

Rhinovirus and Coronavirus Infections

Seminars in Respiratory and Critical Care Medicine, 2007
Rhinoviruses and coronaviruses cause the majority of common colds and play a part in more serious respiratory illnesses that lead to increased morbidity and mortality. Patients who are infants or elderly, have asthma or chronic obstructive pulmonary disease (COPD), or are immunosuppressed have increased frequency of rhinovirus-related respiratory ...
openaire   +2 more sources

Modeling coronavirus infection

Science, 2020
Coronavirus Initially, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was largely associated with respiratory issues. However, we now know that clinical presentation is complex and varied, with complications also seen in the cardiac, neurological, and gastrointestinal systems.
openaire   +1 more source

Ribopuromycylation in Coronavirus-Infected Cells

2020
Ribopuromycylation enables the visualization and quantitation of translation on a cellular level by immunofluorescence or in total using standard western blotting. This technique uses ribosome catalyzed puromycylation of nascent chains followed by immobilization on the ribosome by antibiotic chain elongation inhibitor emetine.
Matthew J, Brownsword, Helena J, Maier, Nicolas, Locker   +2 more
openaire   +2 more sources